CompletedEUCTR 2013-000121-31
Does a GLP-1 receptor agonist change glucose tolerance in antipsychotic-treated patients?
This historical record does not confirm current site availability.
Historical research recordDenmarkSchizophrenia
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Denmark
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Prof., dr. med. Anders Fink-Jensen
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2013-000121-31
- Official title
Show the full official title
Does a GLP-1 receptor agonist change glucose tolerance in antipsychotic-treated patients?
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Denmark
Registry details
Historical country statuses
- Denmark — Completed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Prof., dr. med. Anders Fink-Jensen.
